Susquehanna Fundamental Investments LLC Purchases New Shares in Owens & Minor, Inc. (NYSE:OMI)

Susquehanna Fundamental Investments LLC bought a new stake in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 110,373 shares of the company's stock, valued at approximately $1,443,000. Susquehanna Fundamental Investments LLC owned about 0.14% of Owens & Minor at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Owens & Minor by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 8,915,756 shares of the company's stock worth $116,529,000 after purchasing an additional 107,092 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Owens & Minor by 13.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company's stock worth $30,127,000 after acquiring an additional 276,807 shares during the period. Kennedy Capital Management LLC increased its holdings in Owens & Minor by 15.5% in the 4th quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company's stock worth $15,904,000 after acquiring an additional 163,184 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Owens & Minor by 6.0% during the fourth quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company's stock worth $8,142,000 after purchasing an additional 35,105 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in Owens & Minor by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 488,497 shares of the company's stock worth $6,385,000 after purchasing an additional 111,667 shares during the period. 98.04% of the stock is owned by hedge funds and other institutional investors.

Owens & Minor Trading Down 1.1 %

Shares of OMI stock traded down $0.09 on Tuesday, hitting $8.09. 330,530 shares of the company's stock traded hands, compared to its average volume of 1,112,249. The stock has a market capitalization of $624.99 million, a price-to-earnings ratio of -12.42, a P/E/G ratio of 0.20 and a beta of 1.38. The company's fifty day simple moving average is $8.25 and its 200 day simple moving average is $10.94. Owens & Minor, Inc. has a one year low of $6.07 and a one year high of $21.02. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.02. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.70 billion during the quarter, compared to analysts' expectations of $2.68 billion. During the same period in the prior year, the business posted $0.69 EPS. Owens & Minor's quarterly revenue was up 1.5% compared to the same quarter last year. Equities analysts forecast that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its Board of Directors has initiated a stock repurchase plan on Friday, February 28th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 13.6% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.

Insider Activity

In related news, major shareholder Coliseum Capital Management, L acquired 354,901 shares of Owens & Minor stock in a transaction on Monday, March 3rd. The shares were acquired at an average cost of $9.19 per share, with a total value of $3,261,540.19. Following the transaction, the insider now owns 9,824,599 shares in the company, valued at $90,288,064.81. This trade represents a 3.75 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders bought 2,718,412 shares of company stock valued at $24,495,308. Insiders own 3.69% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. UBS Group cut their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Citigroup cut their target price on Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Robert W. Baird boosted their price objective on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Finally, JPMorgan Chase & Co. cut their price target on shares of Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $12.50.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.